Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

    Aug 11, 2023, 10:09 AM by
    RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023
    Full story
  • Phastar Appoints Graham Clark as New Chief Executive Officer

    Aug 10, 2023, 09:23 AM by
    Phastar Appoints Graham Clark as New Chief Executive Officer Phastar Sets Course for Further Growth with New CEO Appointment
    Full story
  • AI-Powered Healthcare: How Chatbots Are Transforming Healthcare

    Aug 10, 2023, 09:23 AM by
    Healthcare chatbots are set to change how we look after our health. In the future, these digital helpers will talk more like humans, making it feel like chatting with a friend. They'll learn from each conversation, offering better advice over time. These chatbots will work alongside doctors, helping screen and understand patients' problems. They'll speak many languages, team up with gadgets like smartwatches to monitor our health, and be available 24/7. Plus, they'll remind us about medicines and appointments, keep our health data safe, and even help with emotional well-being. In short, they'll make healthcare more personal, easy, and accessible for everyone.
    Full story
  • New Illumina CTO, Q2 Updates

    Aug 9, 2023, 16:53 PM by User Not Found
    Bio-IT World | Illumina today announced that Alex Aravanis, CTO, has departed Illumina to pursue an opportunity outside of the company effective immediately. In his place, Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO).
    Full story
  • Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health

    Aug 9, 2023, 09:03 AM by
    Full story
  • ArisGlobal to Relocate Global Headquarters to Boston Area

    Aug 9, 2023, 09:03 AM by
    ArisGlobal's move to the Greater Boston area reflects growth needs and geographically positions the life sciences SaaS provider among leading biopharmaceutical organizations.
    Full story
  • Huateng Pharma Develops CAS NO.156-83-2 (Minoxidil Intermediate) Against Hair Loss

    Aug 9, 2023, 09:03 AM by
    About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818
    Full story
  • Recent Cash Injection Boosts VectorBuilder to Unicorn Status

    Aug 9, 2023, 09:03 AM by
    VectorBuilder's latest cash injection drives them towards a CDMO facility for the manufacturing of plasmids, mRNA, AAV, lentivirus, cell lines, and a variety of viral and non-viral vectors
    Full story
  • Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner

    Aug 9, 2023, 01:00 AM by User Not Found
    Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
    Full story
  • Generate Biomedicines’ R&D Data Platform to Support ML-Driven Drug Discovery

    Aug 8, 2023, 01:00 AM by User Not Found
    Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”
    Full story
  • Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products

    Aug 3, 2023, 10:02 AM by
    Full story
  • Lactabico Joins Biolabs Heidelberg, Establishes EU Presence

    Aug 3, 2023, 09:29 AM by
    The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.
    Full story
  • Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

    Aug 3, 2023, 09:29 AM by
    Full story
  • An AI Tool for Lung Cancer Diagnosis in Indian Populations, Settings

    Aug 3, 2023, 01:00 AM by User Not Found
    Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.
    Full story
  • SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN ACQUISITION

    Aug 2, 2023, 09:05 AM by
    Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.
    Full story
  • Expert Speaker Lineup Revealed for Award Winning RBQM Event

    Aug 2, 2023, 09:05 AM by
    Expert Speaker Lineup Revealed for Award Winning RBQM Event Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
    Full story
  • Titian Software enters a 3-year agreement with leading life science company

    Aug 2, 2023, 09:05 AM by
    Titian Software LTD and Evotec have signed a 3-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.
    Full story
  • EmendoBio Scientists Participate in National Neutropenia Network Patient Retreat

    Aug 2, 2023, 09:05 AM by
    Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment
    Full story
  • The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change

    Aug 2, 2023, 09:05 AM by
    The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.
    Full story
  • DNAnexus and BigOmics Analytics Join Forces to Improve Proteomics and Transcriptomics Data Visualization and Interpretation

    Aug 2, 2023, 09:05 AM by
    DNAnexus announced a collaboration with BigOmics Analytics to provide customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.
    Full story
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96 (current)
  • 97
  • 98
  • 99
  • 100
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy